We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$979M
AUM Growth
+$54.4M
Cap. Flow
+$29.2M
Cap. Flow %
2.98%
Top 10 Hldgs %
53.04%
Holding
82
New
26
Increased
9
Reduced
17
Closed
20

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$19.5M
2
MSFT icon
Microsoft
MSFT
+$17.1M
3
DHR icon
Danaher
DHR
+$15.6M
4
BFH icon
Bread Financial
BFH
+$15M
5
ARMK icon
Aramark
ARMK
+$14.1M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$29.9M
2
ATNX
Athenex, Inc. Common Stock
ATNX
+$23.1M
3
CPRT icon
Copart
CPRT
+$20.1M
4
PRPL icon
Purple Innovation
PRPL
+$19.5M
5
JD icon
JD.com
JD
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 18.16%
2 Technology 13.08%
3 Communication Services 9.78%
4 Industrials 8.73%
5 Financials 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMQ
51
Trilogy Metals
TMQ
$656M
$3.58M 0.37%
1,673,461
– –
CARM
52
DELISTED
Carisma Therapeutics
CARM
$3.41M 0.35%
65,584
-20,000
-23% -$944K
RAPT
53
CALL
DELISTED
RAPT Therapeutics
RAPT
$3.33M 0.34%
+18,750
New +$3.09M
GEG icon
54
Great Elm Group
GEG
$69.3M
$3.07M 0.31%
1,259,049
– –
PDAC
55
DELISTED
Peridot Acquisition Corp.
PDAC
$2.98M 0.3%
+280,000
New +$3.29M
MSACU
56
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
$2.96M 0.3%
+300,000
New +$3.05M
EUCRU
57
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$2.01M 0.21%
200,000
– –
IFRX icon
58
InflaRx
IFRX
$271M
$1.56M 0.16%
+400,000
New +$2.05M
ACET icon
59
Adicet Bio
ACET
$74.7M
$1.31M 0.13%
+6,250
New +$1.43M
XCUR icon
60
Exicure
XCUR
$8.54M
$740K 0.08%
2,263
– –
RXDX
61
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$730K 0.07%
+40,000
New +$826K
CRC icon
62
California Resources
CRC
$4.62B
$703K 0.07%
29,199
– –
AUPH icon
63
CALL
Aurinia Pharmaceuticals
AUPH
$2.11B
– –
-200,000
Closed -$2.77M
CPRT icon
64
Copart
CPRT
$27.5B
– –
-630,360
Closed -$20.1M
DIS icon
65
PUT
Walt Disney
DIS
$181B
– –
-30,600
Closed -$5.54M
GOOS
66
Canada Goose Holdings
GOOS
$856M
– –
-181,700
Closed -$5.41M
IOVA icon
67
PUT
Iovance Biotherapeutics
IOVA
$2.87B
– –
-300,000
Closed -$13.9M
JD icon
68
JD.com
JD
$44.5B
– –
-174,500
Closed -$15.3M
PD icon
69
CALL
PagerDuty
PD
$902M
– –
-52,300
Closed -$2.18M
PRPL icon
70
Purple Innovation
PRPL
$41.7M
– –
-23,720
Closed -$19.5M
SRI icon
71
Stoneridge
SRI
$213M
– –
-348,301
Closed -$10.5M
STEM icon
72
Stem
STEM
$52.7M
– –
-14,300
Closed -$5.85M
TENB icon
73
PUT
Tenable Holdings
TENB
$4.01B
– –
-73,200
Closed -$3.83M
WDAY icon
74
PUT
Workday
WDAY
$44.4B
– –
-25,000
Closed -$5.99M
XBI icon
75
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-300,000
Closed -$42.2M
1 2
3
4

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Kingdon Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Kingdon Capital Management held 82 positions worth $979M, up 5.9% from $925M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Kingdon Capital Management's Q1 2021 filing shows 26 new, 9 increased, 17 reduced and 20 closed positions. Its largest new stake was Microsoft: 73,900 shares worth $17.4M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $29.9M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

  • Kingdon Capital Management's largest Q1 2021 buy was Microsoft: 73,900 shares worth $17.4M.
  • Kingdon Capital Management added most to Meta Platforms (Facebook) in Q1 2021, an estimated $19.5M increase.
  • Kingdon Capital Management's biggest Q1 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $29.9M.
  • Kingdon Capital Management fully exited Copart in Q1 2021, selling an estimated $20.1M.
  • Kingdon Capital Management's ten largest holdings make up 53% of its $979M portfolio in Q1 2021.
  • Kingdon Capital Management opened 26 new positions and closed 20 in Q1 2021.
  • Kingdon Capital Management's portfolio value rose 5.9% quarter-over-quarter to $979M.

Based on Kingdon Capital Management's 13F filing for Q1 2021, filed 17 May 2021.